Publications by authors named "David A Fishman"

Claim this Profile
I
Immunohistochemical detection of promyelocytic leukemia zinc finger and histone 1.5 in uterine leiomyosarcoma and leiomyoma.
Mazdak Momeni, Tamara Kalir, Sara Farag, Yayoi Kinoshita, Taisha Y Roman, David A Fishman

Reprod Sci· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early detection of ovarian cancer with conventional and contrast-enhanced transvaginal sonography: recent advances and potential improvements.
Arthur C Fleischer, Andrej Lyshchik, Makiko Hirari, Ryan D Moore, Richard G Abramson, David A Fishman

J Oncol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The NF-κB pathway mediates lysophosphatidic acid (LPA)-induced VEGF signaling and cell invasion in epithelial ovarian cancer (EOC).
Sonia Dutta, Feng-qiang Wang, Hai-shan Wu, Thayer J Mukherjee, David A Fishman

Gynecol Oncol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MMP-1-PAR1 axis mediates LPA-induced epithelial ovarian cancer (EOC) invasion.
Feng-qiang Wang, Jessica Fisher, David A Fishman

Gynecol Oncol· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Soluble epidermal growth factor receptor: a biomarker of epithelial ovarian cancer.
Andre T Baron, Jacqueline M Lafky, Cecelia H Boardman, Elsa M Cora, Marites C Buenafe, David A Fishman

Cancer Treat Res· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lysophosphatidic acid and invasion.
Fengqiang Wang, David A Fishman

Cancer Treat Res· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The dire need to develop a clinically validated screening method for the detection of early-stage ovarian cancer.
Sonia Dutta, Feng-Qiang Wang, David A Fishman

Biomark Med· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarkers for ovarian cancer detection and therapy.
Sonia Dutta, Feng-qiang Wang, Adrien Phalen, David A Fishman

Cancer Biol Ther· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lysophosphatidic acid (LPA) effects on endometrial carcinoma in vitro proliferation, invasion, and matrix metalloproteinase activity.
Feng-qiang Wang, Edgardo V Ariztia, Leslie R Boyd, Faith R Horton, Yoel Smicun, David A Fishman

Gynecol Oncol· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in sonographic detection of ovarian cancer: depiction of tumor neovascularity with microbubbles.
Arthur C Fleischer, Andrej Lyshchik, Rochelle F Andreotti, Misun Hwang, Howard W Jones, David A Fishman

AJR Am J Roentgenol· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New frontiers for ovarian cancer risk evaluation: proteomics and contrast-enhanced ultrasound.
Sonia Dutta, Feng-qiang Wang, Arthur C Fleischer, David A Fishman

AJR Am J Roentgenol· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VEGFR-2 silencing by small interference RNA (siRNA) suppresses LPA-induced epithelial ovarian cancer (EOC) invasion.
Feng-qiang Wang, Elaine Barfield, Sonia Dutta, Tarah Pua, David A Fishman

Gynecol Oncol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Roles of LPA in ovarian cancer development and progression.
Tarah L Pua, Feng-qiang Wang, David A Fishman

Future Oncol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic parameters to differentiate benign from malignant ovarian masses with contrast-enhanced transvaginal sonography.
Arthur C Fleischer, Andrej Lyshchik, Howard W Jones, Marta A Crispens, Rochelle F Andreotti, David A Fishman

J Ultrasound Med· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LPA receptor 2 mediates LPA-induced endometrial cancer invasion.
Joanie Mayer Hope, Feng-Qiang Wang, Jill S Whyte, Edgardo V Ariztia, Walid Abdalla, David A Fishman

Gynecol Oncol· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
S1P induced changes in epithelial ovarian cancer proteolysis, invasion, and attachment are mediated by Gi and Rac.
Kathleen M Devine, Yoel Smicun, Joanie Mayer Hope, David A Fishman

Gynecol Oncol· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contrast-enhanced transvaginal sonography of benign versus malignant ovarian masses: preliminary findings.
Arthur C Fleischer, Andrej Lyshchik, Howard W Jones, Marta Crispens, Mary Loveless, David A Fishman

J Ultrasound Med· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent e-cadherin loss in ovarian carcinoma cells.
Karen D Cowden Dahl, Jaime Symowicz, Yan Ning, Elisa Gutierrez, David A Fishman

Cancer Res· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lysophosphatidic acid (LPA) promotes E-cadherin ectodomain shedding and OVCA429 cell invasion in an uPA-dependent manner.
Orlando D Gil, Catherine Lee, Edgardo V Ariztia, Feng-Qiang Wang, Phillip J Smith, David A Fishman

Gynecol Oncol· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
S1P and LPA have an attachment-dependent regulatory effect on invasion of epithelial ovarian cancer cells.
Yoel Smicun, Orlando Gil, Kate Devine, David A Fishman

Gynecol Oncol· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A robust biomarker discovery pipeline for high-performance mass spectrometry data.
Wayne G Fisher, Kevin P Rosenblatt, David A Fishman, Gordon R Whiteley, Alvydas Mikulskis

J Bioinform Comput Biol· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conventional and proteomic technologies for the detection of early stage malignancies: markers for ovarian cancer.
Catherine J Lee, Edgardo V Ariztia, David A Fishman

Crit Rev Clin Lab Sci· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engagement of collagen-binding integrins promotes matrix metalloproteinase-9-dependent E-cadherin ectodomain shedding in ovarian carcinoma cells.
Jaime Symowicz, Brian P Adley, Kara J Gleason, Jeffrey J Johnson, Supurna Ghosh, David A Fishman

Cancer Res· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lysophosphatidic acid down-regulates stress fibers and up-regulates pro-matrix metalloproteinase-2 activation in ovarian cancer cells.
Thuy-Vy Do, Jay C Symowicz, David M Berman, Lance A Liotta, Emanuel F Petricoin, David A Fishman

Mol Cancer Res· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of matrilysin expression by antisense or RNA interference decreases lysophosphatidic acid-induced epithelial ovarian cancer invasion.
Feng-Qiang Wang, Yoel Smicun, Nicholas Calluzzo, David A Fishman

Mol Cancer Res· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis